Andlauer Healthcare Group Inc. (TSE:AND) Director Ronald Martin Skelton Sells 1,500 Shares of Stock

Andlauer Healthcare Group Inc. (TSE:ANDGet Free Report) Director Ronald Martin Skelton sold 1,500 shares of Andlauer Healthcare Group stock in a transaction dated Wednesday, May 8th. The stock was sold at an average price of C$40.87, for a total transaction of C$61,309.95.

Andlauer Healthcare Group Price Performance

Shares of TSE:AND opened at C$39.54 on Monday. The company has a debt-to-equity ratio of 27.24, a quick ratio of 1.66 and a current ratio of 2.52. Andlauer Healthcare Group Inc. has a 52 week low of C$36.76 and a 52 week high of C$48.80. The firm has a market cap of C$770.24 million, a PE ratio of 25.51 and a beta of 0.69. The firm’s fifty day moving average is C$42.07 and its 200-day moving average is C$40.56.

Andlauer Healthcare Group (TSE:ANDGet Free Report) last announced its earnings results on Tuesday, March 5th. The company reported C$0.44 EPS for the quarter, missing the consensus estimate of C$0.49 by C($0.05). The company had revenue of C$169.07 million for the quarter, compared to analyst estimates of C$165.00 million. Andlauer Healthcare Group had a return on equity of 14.53% and a net margin of 10.21%. Sell-side analysts predict that Andlauer Healthcare Group Inc. will post 1.8439434 earnings per share for the current year.

Andlauer Healthcare Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Thursday, March 28th were given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date of this dividend was Wednesday, March 27th. This is an increase from Andlauer Healthcare Group’s previous quarterly dividend of $0.09. Andlauer Healthcare Group’s dividend payout ratio is currently 23.23%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on AND shares. Scotiabank cut their price target on Andlauer Healthcare Group from C$47.50 to C$46.00 and set an “outperform” rating for the company in a research note on Monday, May 6th. Eight Capital reduced their target price on Andlauer Healthcare Group from C$62.00 to C$58.00 and set a “buy” rating on the stock in a report on Thursday, March 7th. TD Securities lowered their price objective on shares of Andlauer Healthcare Group from C$54.00 to C$52.00 and set a “buy” rating for the company in a research report on Monday, May 6th. National Bankshares raised their target price on shares of Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the company a “sector perform” rating in a research report on Thursday, March 7th. Finally, Royal Bank of Canada lowered their price target on shares of Andlauer Healthcare Group from C$43.00 to C$41.00 and set a “sector perform” rating for the company in a report on Monday, May 6th. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of C$49.43.

Check Out Our Latest Stock Analysis on AND

About Andlauer Healthcare Group

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Recommended Stories

Insider Buying and Selling by Quarter for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.